We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
12076
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$35K ﹤0.01%
14
-8
-36% -$20.8K
SEAC
12077
CALL
DELISTED
Seachange International Inc
SEAC
$35K ﹤0.01%
2,935
+1,115
+61% +$19.4K
PEI
12078
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$35K ﹤0.01%
10,316
-2,159
-17% -$14.2K
AKBA icon
12079
PUT
Akebia Therapeutics
AKBA
$260M
$34K ﹤0.01%
98,500
-252,400
-72% -$106K
ASMB icon
12080
Assembly Biosciences
ASMB
$709M
$34K ﹤0.01%
1,330
-2,301
-63% -$53K
BRN icon
12081
Barnwell Industries
BRN
$13.8M
$34K ﹤0.01%
+14,469
New +$39.9K
BYFC icon
12082
CALL
Broadway Financial
BYFC
$112M
$34K ﹤0.01%
+3,975
New +$47.4K
CTSO icon
12083
PUT
Cytosorbents Corp
CTSO
$21.4M
$34K ﹤0.01%
+15,700
New +$36K
BGMS
12084
Bio Green Med Solution Inc
BGMS
$5.9M
$34K ﹤0.01%
9
+3
+50% +$18.1K
DAKT icon
12085
Daktronics
DAKT
$947M
$34K ﹤0.01%
11,360
-22,266
-66% -$74.5K
PRQR icon
12086
CALL
ProQR Therapeutics
PRQR
$327M
$34K ﹤0.01%
43,200
+11,000
+34% +$8.2K
PYXS icon
12087
Pyxis Oncology
PYXS
$277M
$34K ﹤0.01%
+14,466
New +$38.5K
TUSK icon
12088
CALL
Mammoth Energy Services
TUSK
$152M
$34K ﹤0.01%
+15,300
New +$34.3K
GATO
12089
CALL
DELISTED
Gatos Silver, Inc.
GATO
$34K ﹤0.01%
11,800
-12,200
-51% -$42.8K
LTRPA
12090
CALL
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$34K ﹤0.01%
44,600
-2,400
-5% -$3.09K
PLXP
12091
PUT
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$34K ﹤0.01%
13,900
-66,300
-83% -$184K
ASAP
12092
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$34K ﹤0.01%
11,435
-6,120
-35% -$27K
CO
12093
CALL
DELISTED
Global Cord Blood Corporation
CO
$34K ﹤0.01%
11,500
-22,800
-66% -$70.7K
CXDO icon
12094
PUT
Crexendo
CXDO
$213M
$33K ﹤0.01%
+10,800
New +$31.6K
DRRX
12095
CALL
DELISTED
DURECT Corp
DRRX
$33K ﹤0.01%
6,840
-2,900
-30% -$13.9K
IDN icon
12096
Intellicheck
IDN
$57.6M
$33K ﹤0.01%
16,492
-8,521
-34% -$17.2K
KULR icon
12097
CALL
KULR Technology Group
KULR
$123M
$33K ﹤0.01%
2,625
-938
-26% -$12.5K
LITS
12098
PUT
Lite Strategy Inc
LITS
$34M
$33K ﹤0.01%
2,710
-445
-14% -$4.84K
NRXP icon
12099
PUT
NRX Pharmaceuticals
NRXP
$157M
$33K ﹤0.01%
5,450
-3,910
-42% -$51.4K
SYRE icon
12100
Spyre Therapeutics
SYRE
$8.25B
$33K ﹤0.01%
+2,608
New +$91.4K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.